Anti-PR3 ANCAs can be detected in ~ 70–75% of GPA patients, with variations across different ethnic groups and depending on whether the disease is in the active or quiescent phase; anti-MPO ANCAs occur in ~ 15–20% of GPA patients. The gene discussed is MPO; the disease is granulomatosis with polyangiitis.